The story of Viagra presents a challenging picture for shareholders. While the initial release generated substantial profits, the expiration of its exclusive rights opened the floodgates to generic versions, https://redhotbookmarks.com/story21586220/sildenafil-and-big-pharma-a-precarious-investment